
Organometallics
Found 4421 products of "Organometallics"
Iohexol
CAS:Controlled ProductApplications Imaging agent.
References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),Formula:C19H26I3N3O9Color and Shape:Off-WhiteMolecular weight:821.14(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid
CAS:Purity:98%Molecular weight:252.10000610351562Oxaliplatin
CAS:Controlled ProductApplications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),Formula:C8H14N2O4PtColor and Shape:White To Off-WhiteMolecular weight:397.295-Amino-2,4,6-triiodoisophthalic Acid
CAS:Controlled ProductImpurity Iohexol EP Impurity K
Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.Formula:C8H4I3NO4Color and Shape:NeatMolecular weight:558.84Dihydroxy Oxaliplatin-Pt(IV)
CAS:Controlled ProductApplications An Oxaliplatin (O845075) derivative. An orally active antitumor cyclohexanediamine-Pt(IV) complex. Oxaliplatin impurity C as per EP.
References Yamashita, T., et al.: Biol. Pharma. Bull., 16, 1014 (1993),Formula:C8H16N2O6PtColor and Shape:White To Light YellowMolecular weight:431.3Oxaliplatin-d10
CAS:Controlled ProductApplications Oxaliplatin-d10, is the labeled analogue of Oxaliplatin (O845075), which is platinum-based antineoplastic agent that is used in cancer chemotherapy.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),Formula:C8H4D10N2O4PtColor and Shape:NeatMolecular weight:407.35(2-Butoxy-4-fluorophenyl)boronic acid
CAS:Formula:C10H14BFO3Purity:95.0%Color and Shape:SolidMolecular weight:212.03[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum
CAS:Applications [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN')diiodoplatinum is a potential antitumor agent. Impurity of Oxiplatin (O845075), third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
References Kidani, Y. et al.: Biomed. Pharmacther., 43, 261 (1989); Noji, M. et al.: J. Med. Chem., 24, 508 (1981); Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),Formula:C6H14I2N2PtColor and Shape:NeatMolecular weight:563.085-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
CAS:Controlled ProductStability Hygroscopic
Applications An intermediate used in the synthesis of imaging agents such as Iohexol (I729500).
References Priebe, H., et al.: J. Clin. Pharm. Ther., 24, 227 (1999),Formula:C16H20I3N3O7Color and Shape:NeatMolecular weight:747.06Transplatin
CAS:Applications Transplatin is the trans stereoisomer impurity of Cisplatin (C499500), an antineoplastic used in the treatment of sarcomas, some carcinomas, lymphomas, and germ cell tumors. Transplatin binds to DNA but does not exhibit the same useful pharmacological effect as its cis stereoisomer.
References Cersosimo, R.J.: Cancer Treat. Rev., 16, 195 (1989); Takeiri, A. et al.: Genes Environ., 29, 89 (2007); Giraud-Panis, M.-J. et al.: Pharmacol. Therap., 85, 175 (2000);Formula:Cl2H6N2PtColor and Shape:Light YellowMolecular weight:300.04Gadopentetic Acid
CAS:Controlled ProductApplications: Gadopentetic Acid is a magnetic resonance contrast agent being used to develop a new platform for the delivery of therapeutic and imaging agents simultaneously to the colon.
References Jin, M., et al.: Mol. Pharm, 13, 2457-2465 (2016)Formula:C14H20GdN3O10Color and Shape:NeatMolecular weight:547.57(2-Ethoxy-4-methylpyridin-3-yl)boronic acid
CAS:Purity:95+%Color and Shape:SolidMolecular weight:181.0(3-((4-Chlorophenoxy)methyl)phenyl)boronic acid
CAS:Formula:C13H12BClO3Purity:95.0%Color and Shape:SolidMolecular weight:262.5(4-(Diisopropylcarbamoyl)-2-ethoxypyridin-3-yl)boronic acid
CAS:Purity:95+%Molecular weight:294.1600036621094(5,6-Difluoropyridin-3-yl)boronic acid
CAS:Formula:C5H4BF2NO2Purity:96%Color and Shape:No data available.Molecular weight:158.9

